Print Page   |   Contact Us   |   Sign In   |   Register
Grant Writing Guide
Share |

How to Apply For a Grant

Obtaining Chapter Funding for Continuing Pharmaceutical Education & Events

A service of the Texas Society of Health-System Pharmacists

Click here for the .pdf of the article "How To Apply For a Grant"

 

Step 1: Getting Started What can and cannot be funded?

• Educational grants may be given only for legitimate educational or scientific purposes. Grants must comply with internal company policies and guidelines, which reflect the requirements and mandates of the Office of the Inspector General Guidance, the Accreditation Council for Continuing Medical Education (CME) Guidelines and the PhRMA Code on Interactions with Healthcare Professionals.

• Grants may be given for live educational programs, as well as educational publications and other types of enduring materials (eg. interactive web, CD rom, audio tapes, etc) provided that the programs or materials are advertised and open to a broad audience beyond members of the requesting institution. Fellowships or career development awards may be considered in limited circumstances.

• Grants cannot have any strings attached. Grants cannot be tied, in any way, to past, present, or future prescribing, purchasing, or recommending (including formulary recommendations) of any drug. Any documentation that is a part of or accompanies a grant request suggesting that the grant is tied, in any way, to past, present, or future prescribing, purchasing, or recommending of any drug will cause the grant request to be rejected.

• Grants cannot be used to defray the grant requestor’s ordinary operating expenses (i.e. overhead expenses of activities that the requestor is already required to perform or customarily performs, including business meetings, or education that is a routine and required part of an educational program, eg. “grand rounds” with internal speakers etc.)

• Grants sought for the purchase of journal subscriptions, or similar items are generally not permitted as these items may be considered gifts or as part of operating expenses.

• Grants cannot involve payment for travel, housing expenses or time spent for health care professionals attending third party educational events, unless (i) the individuals involved are medical students, residents, fellows, and other healthcare professionals in training, (ii) the grant permits individuals selected from this group by the academic or training institution receiving the grant to attend major educational, scientific, or policy-making meetings of national, regional, or specialty medical associations, and (iii) such individuals are not attending the event for the purpose of making or attending presentations relating to Company products.

• Grants may not be used to fund payments for exhibit space, consulting or other services or goods provided to the company, company promotional activities or events, or any program where any of the speakers are company employees.

• Grants may not cover the costs of entertainment or recreational events.

Who can and cannot receive funding?

• Accredited continuing education providers, health-related academic societies and organizations, education vendors, teaching hospitals, educational institutions and other groups within the United States who have the potential to provide high quality education to advance healthcare are eligible to apply for an educational grant.

• In order to avoid any conflict of interest, the company does not make grants to any of its customers, including HMOs, PPOs, GPOs, etc., or any doctor or group of doctors in private practice. The only customers or potential customers that may be eligible for a grant are teaching hospitals and educational institutions whose mission includes public health education.

• Applicants who have received past grant funding, but have not provided a budget reconciliation for the past program are not eligible for funding.

Budget guidelines

• Grants must be limited to a reasonable estimate of the cost of the grant-funded activities.

• Grants may be issued to support only the costs associated with the development, delivery or evaluation of the educational program, resources, or materials.

• Grants may not cover solely the cost of meals. It is acceptable for a portion of a grant to cover meals/refreshments only if the meals/refreshments are (i) modest and conducive to discussion among faculty and healthcare professional attendees, and (ii) of substantially less value in terms of time and money than the educational portion of the event funded by the grant.

• Recipients of funding may be required to submit a completed budget reconciliation form within 90 days of the program end date.

Application Requirements

• The information submitted by the grant requestor must include a reasonably detailed description of the program or activity for which funding is requested, including educational need, general subject matter, learning objectives, instructional methods, evaluation plan, time, place, speaker qualifications and institutional affiliation(s), and anticipated invitees or audience. 

Step 2: Gather Information

Gather the information listed below before going online to apply for a grant. Please note that not all of this information will be utilized on every site, but it is good to gather the information beforehand. Consider applying for a grant from multiple sites as some sites have a greater interest in specific topics than others.

Contact Information:

1. Name

2. E-mail address

3. Phone Number

4. Fax Number

Organization Information:

1. Legal Name

2. Tax ID Number (Do NOT use the TSHP Tax ID number)

3. Tax Status - (For Profit or Not for Profit)

4. Mailing Address

5. Overnight Delivery Address

6. Phone Number

7. Fax Number

Information About the Program You Would Like Funded

1. Title of the Program

2. Description of Program A one paragraph overview of the program, e.g. A symposium on the importance of diabetes management.

3. Statement of Educational Need

4. Learning Objectives

5. Instructional Methods

6. Evaluation Plan

7. Program Agenda

8. Other information necessary for the complete review of the grant request. (Optional)

9. Name of speaker(s) and institutional affiliation

10. Is this an Accredited CE Program? - Yes / No

11. Program Audience

12. Program Date/Duration

13. Program Location

14. Program Budget

In the event that TSHP is your CE provider, you may need the following information:

TSHP Information:

Mailing Address:

3000 Joe DiMaggio #30-A

Round Rock, TX 78665-3994

Contact Person: Paul F. Davis, R.Ph. Executive Director

Paul.davis@tshp.org

Phone: 800-242-8747

Fax: 512-852-8514

Tax ID: 23-7296288

Step 3: Find a Company with Interest in the Topic

Below is a list of topics that different companies have expressed an interest in program sponsorship. This list is not all inclusive as interests and technology change frequently. Once you locate your topic, match the number(s) at the end of the topic name with the company listing at the end of this packet. For example, if you are interested in funding a program concerning “Anesthesia” topics, find #20 in the company listing section. Number 20 corresponds with Roche Labs. Multiple numbers indicate that several companies are interested in funding programs for that topic.

NOTE: Companies such as Amgen, Merck, Pfizer, Centocor, GlaxoSmithKline, Guidant, UCB Pharma, and Wyeth have expressed interest in sponsoring topics of multiple interests including some not listed below.

Areas of Interest:

• Anesthesia 20

• Anticoagulation 6

o Deep Vein Thrombosis (DVT) 6, 21

o Prophylaxis & Treatment of DVT & Acute Coronary Syndrome 21

o Prophylaxis of DVT with High Risk Surgery 21

• Arthritis 16, 19

o Osteoarthritis 21

o Rheumatoid Arthritis 1, 6, 21

• Cardiology 3, 5, 6, 15, 16, 19, 20, 21, 22, 24, 25

o Acute Coronary Syndrome 6, 21

o Angina 3

o Atrial Fibrillation 21

o Cardiac Dysrhythmias 21

o Cardiovascular Disease 23, 28

o Coronary Artery Disease16

o Dyslipidemia 3, 6, 16, 21, 22, 25

ƒ non-LDL related 21

o Electrocardiography 6

o Heart Failure 3, 23

o Hypertension 3, 5, 6, 8, 16

o Metabolic Syndrome 3, 6, 21

o Myocardial Infarction 3

o Nuclear Cardiology 6

o Obesity and Related Cardiovascular & Metabolic Risk Factors 21

o Peripheral Arterial Disease 6, 21

o Risk Factor Management 19, 21

o Stroke 3, 5, 6

• Clinical Trial Process & Investigator Training 19

• Critical care 15

• Cystic Fibrosis 3

• Disease Awareness 19

• Drug Development Process 19

• Dermatology 2, 21, 27

o Acne 21

o Actinic Keratosis - Skin Cancer 21

o Aesthetic Dermatology 21

ƒ Lipoatrophy 21

o Atopic Dermatitis – Psoriasis, Eczema 21

o Chronic Idiopathic Urticaria 21

o Onychomycosis & Podiatric Skin Conditions 21

o Rosacea 21

• Diabetes Mellitus 1, 6, 15, 16, 19, 21, 25

o Insulin Resistance 6

o Insulin Therapy 19

o Nephropathy - Prevention of Progression in Type II Diabetes 21

o Type I 21

o Type II 3, 21

• Endocrinology

o Growth Disorders 15, 19

• Gastrointestinal (GI) Disorders 3, 24, 25, 28

o Acid Related Disorders 3

o Crohn’s Disease 4, 6

o Irritable Bowel Syndrome 6, 25

o Nausea & Vomiting, Postoperative

ƒ Prophylaxis & Treatment 16, 21

o Ulcerative Colitis 6

• Health Care Disparities 19

• Hematology 4

o Hemophilia 28

• Immunology 9, 28

o Graft vs. Host Disease 6

o Lupus 6

o Multiple Sclerosis 4, 6, 19

• Immunizations & Vaccinations

o Immunization Update 16

o Pediatric Vaccines 28

• Infections 3, 22

o Antibiotics, Antimicrobials 22

ƒ Pharmacokinetics & Pharmacodynamics 3

o Antibiotic Resistance Patterns 3, 21

o Antimicrobial Surveillance Programs 3

o Bacteria and Infection 3

o Bacterial meningitis 3

o Complicated Skin and Soft Tissue Infections 3, 16

o Epidemiology 21

o HIV/AIDS 1, 6, 16, 19, 20, 24

o Hepatitis B 6

o Hepatitis C 6, 20

o Herpes Zoster & Post-Herpetic Neuralgia 16

o Human Papilloma Virus 16

o Infectious Disease 6, 19, 28

o Intra-abdominal Infections 3

o Nosocomial Infections 3

o Onychomycosis 21

o Pneumonia

ƒ Community-Acquired 2, 16

ƒ Ventilator-Associated 3

o Respiratory Tract Infections 19, 21

o Systemic fungal infections 16

• Medical Imaging

o Diagnostics 4, 6

o Electrocardiography 6

o Nuclear Cardiology 6

 

• Men’s Health 24

o Androgen Ablation Therapy 21

o Andrology 24

o Benign Prostatic Hyperplasia 5, 21

o Erectile Dysfunction 19, 21

o Ejaculatory Dysfunction 21

o Male Urology 15

• Metabolism 21

• Neurology 3, 5, 20, 21

o Alzheimer’s Disease 8

o Dementia 19

o Epilepsy 19

o Migraine 16, 19

o Pain Conditions 1, 19

ƒ Neuropathic Pain 3

ƒ Nociceptive Pain 3

• Obesity and Related Cardiovascular & Metabolic Risk Factors 21

• Oncology 1, 2, 3, 4, 6, 9, 15, 16, 19, 21, 22, 24, 28

o Actinic Keratosis - Skin Cancer 21

o Angiogenesis 3

o Bladder Cancer 6, 20

o Breast Cancer 3, 6, 19, 21

o Chemotherapy & Supportive Care 21, 25

o Colorectal Cancer 3, 6, 19, 20, 21

o Gastric Cancer 21

o Genomics used for individualized cancer treatment 10

o GI Stromal Tumor 19

o Gynecologic Cancer 21

o Head & Neck Cancer 6, 21

o Lung Cancer 3, 6, 21

o Metastatic Melanoma 6

o Multi-Tumors 6 o Myelogenous Leukemia 6

o Nausea, Vomiting - with chemotherapy 21

o Other 6

o Ovarian Cancer 6, 21

o Pancreatic Cancer 6, 21

o Prostate Cancer 3, 21

o Renal Cell Carcinoma 19

o Targeted Therapies in Cancer 3

o Thyroid Cancer 3

• Ophthalmology 16, 19

• Pediatrics 1

o Pediatric Vaccines 28

• Plastic Surgery 21

• Podiatry 21

• Psychiatry 14, 19

o Alcohol Dependence 8

o Alzheimer’s Disease 8

o Anxiety 8, 28

o Autism 6

o Bipolar Disorder 3, 6, 14

o Dementia 8,19

o Depression 6, 8, 28

o Dual Diagnosis with Substance Abuse 3

o Mental Health 6, 14, 15, 19, 24

o Mood disorders 19

o Psychosis 19, 28

o Schizophrenia 3, 6, 14

• Pulmonary Arterial Hypertension 19

• Renal & Urology 5, 15, 16, 19, 24

o Alpha-Blockers usage in ureteral stone passage 21

o Bladder outlet obstruction 21

o Lower Urinary Tract Symptoms 21

o Nephrology 2

o Nephropathy - Prevention of Progression in Type 2 Diabetes 21

o Nocturia/Bedwetting (Adults & Pediatric) 21

o Urinary Retention 21

• Reproductive Health

o Contraception 4, 28

• Respiratory 3, 19, 22

o Allergy 22

o Asthma 3, 5, 16, 21

o Bronchitis 21

o Chronic Obstructive Pulmonary Disease 3, 19

o Respiratory Tract Infections 19, 21

o Rhinitis 3, 19

ƒ Perennial Allergic Rhinitis 21

ƒ Seasonal Allergic Rhinitis 21

o Sinusitis 21

o Smoking Cessation 19

• Rheumatology 2, 6, 28 o Rheumatoid Arthritis 1, 6, 21

• Skeletal/Bones o Osteoarthritis 21

o Osteoporosis 15, 16, 20, 21, 25, 28

ƒ Postmenopausal21

• Sleep Disorders 21 o Insomnia 19, 21

• Thyroid Disease 8

• Transplantation 28

o Bone Marrow Transplant 6

o Cellular Transplant 6

o Solid Organ Transplant 6 • Women’s Health 1, 19, 24, 27

o Gynecology 24

o Menopause 4, 28

o Postmenopausal Osteoporosis 21

• Vascular Biology 9

• Web site development 13

• Virology 5, 6

o Cytomegalovirus 11

o HIV/AIDS 6, 11, 16, 19, 20, 24

o Hepatitis B 6, 11 o Hepatitis C 6, 11, 20

o Herpes Zoster & Post-Herpetic Neuralgia 16

o Human Papilloma Virus (HPV) 1

o Influenza 11

See PDF for addresses and contact information.

Step 4: Proceed with the Application Process

Once you determine which company you intend to apply to for grant funding, find that company’s corresponding contact information at the end of this packet. Each company varies with its preferred method of communication. Some companies prefer that you contact your local representative, while others have online applications. Each website has instructions for filling out all necessary components of the application. Read carefully and make sure to download any forms they may provide that will make uploading requested information much easier (budget forms, etc.). If they provide additional forms to fill out, it is best to complete the forms by-hand before proceeding with the application process to avoid the potential for the program to “time out” and lose the information you have entered. In other words, gather all the information and then fill out the application.

Step 5: Wait for a Response

The company will contact you via the email you provide on the application. There may be an immediate acknowledgment, but typically it will take at least 4 weeks before you receive a response and/or requests for more information.

Community Search
Sign In
Sign In securely
Calendar
Featured Members

OKLAHOMA SOCIETY OF HEALTH-BASED PHARMACISTS
PO BOX 2371
OKLAHOMA CITY, OK  73101